Status:
COMPLETED
Contrast Enhanced MRI of the Prostate
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18-75 years
Brief Summary
Prostate cancer detection and disease progression monitoring relies on systematic multi-core biopsies. Minimal invasive imaging capacities for lesion targeting and monitoring are badly needed. The pur...
Detailed Description
The aim of the study is to perform contrast-enhanced (CE) magnetic resonance imaging (MRI) at OHSU on subjects with diagnosed prostate cancer. This pilot project will study 20 subjects prior to their ...
Eligibility Criteria
Inclusion
- Men, age \>18 years.
- Any patient scheduled for prostate biopsy repeat or radical prostatectomy.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Patients who would be normally excluded from undergoing an MRI examination - patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field.
- Patients who are unable to cooperate for an MRI exam.
- Major surgery within a month of enrollment.
- Prostate biopsy six weeks prior to enrollment.
- Subject-reported reaction to gadolinium contrast reagent.
Key Trial Info
Start Date :
February 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2018
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT02245282
Start Date
February 10 2017
End Date
December 12 2018
Last Update
September 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Imaging Research Center, OHSU
Portland, Oregon, United States, 97239